Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Equity Capital Management H1N1 Vaccines and Hard to Treat Diseases (HTDS)

Posted on: Monday, 21 September 2009, 08:04 CDT

LONDON, Sept. 21 /PRNewswire-FirstCall/ - Equity Capital Management (ECM) http://www.equitycapitalmanagement.co.uk has completed a preliminary review of the HTDS business model. ECM is providing an informative report to all HTDS followers at the following link http://www.equitycapitalmanagement.co.uk/ourprojects.html

Equity Capital Management PLC, (ECM) believes that in the current economic climate there are distinct opportunities to purchase under-performing asset-rich businesses ECM business model is to target such under performing companies. ECM believes HTDS is a good target for the acquisition because it is an under-performing and undervalued company, with a great potential. ECM has not been paid in cash or stock for this report on HTDS. ECM may invoice the company for a voluntary cash payment should its report prove to be of assistance to the company.

The entire report will be posted on ECM web site: http://www.equitycapitalmanagement.co.uk/ourprojects.html

The report may also be available on www.pinksheets.com under the "FILING TAB" with the sub heading "Management Discussion and Analysis" or this direct link http://www.pinksheets.com/pink/quote/quote.jsp?symbol=htds

Disclosure

ECM is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Please read our report for complete risks and disclosures.

CONTACT: www.equitycapitalmanagement.co.uk

SOURCE Hard to Treat Diseases


Source: PR Newswire

More News in this Category


Related Articles



Rating: 3.0 / 5 (1 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required